Torrente-López, A.; Hermosilla, J.; Navas, N.; Cuadros-RodrÃguez, L.; Cabeza, J.; Salmerón-GarcÃa, A.
The Relevance of Monoclonal Antibodies in the Treatment of COVID-19. Vaccines 2021, 9, 557.
https://doi.org/10.3390/vaccines9060557
AMA Style
Torrente-López A, Hermosilla J, Navas N, Cuadros-RodrÃguez L, Cabeza J, Salmerón-GarcÃa A.
The Relevance of Monoclonal Antibodies in the Treatment of COVID-19. Vaccines. 2021; 9(6):557.
https://doi.org/10.3390/vaccines9060557
Chicago/Turabian Style
Torrente-López, Anabel, Jesús Hermosilla, Natalia Navas, Luis Cuadros-RodrÃguez, José Cabeza, and Antonio Salmerón-GarcÃa.
2021. "The Relevance of Monoclonal Antibodies in the Treatment of COVID-19" Vaccines 9, no. 6: 557.
https://doi.org/10.3390/vaccines9060557
APA Style
Torrente-López, A., Hermosilla, J., Navas, N., Cuadros-RodrÃguez, L., Cabeza, J., & Salmerón-GarcÃa, A.
(2021). The Relevance of Monoclonal Antibodies in the Treatment of COVID-19. Vaccines, 9(6), 557.
https://doi.org/10.3390/vaccines9060557